Scientific advancements for cancer patients are quickly evolving and more promising than ever before. At the heart of today’s complex and highly personalized approach to cancer is molecular diagnostics. Abbott Molecular is a pioneer and leader in oncology molecular diagnostics with its Vysis FISH assays and Abbott RealTime IDH2 assay.
The powerful insight of Vysis FISH and Abbott RealTime has never been more relevant or instrumental in enabling the most informed decisions during every step of the patient journey from screening through monitoring.
We focus on developing molecular products in the areas of the most identified patient need. Our 300-plus Vysis DNA FISH probes are designed for hematology and breast, lung, bladder, and other solid tumors.
IVD/CE
Vysis IntelliFISH offers smart features with processing flexibility, simplified workflow and reduced inventory management to help reduce operating costs.
Our end-to-end solution brings additional operational efficiencies that can help save time and money.
Ask your Abbott Representative about the significant improvements IntelliFISH can deliver to your laboratory.
Links which take you out of Abbott worldwide websites are not under the control of Abbott, and Abbott is not responsible for the contents of any such site or any further links from such site. Abbott is providing these links to you only as a convenience, and the inclusion of any link does not imply endorsement of the linked site by Abbott. The website that you have requested also may not be optimised for your screen size.
Please be aware that the website you have requested is intended for the residents of a particular country or countries, as noted on that site. As a result, the site may contain information on pharmaceuticals, medical devices and other products or uses of those products that are not approved in other countries or regions.
